Making your biotech program investor-ready
Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…
Jim Gallagher2021 年 1 月 21 日
An Introduction to Asset Evaluation for Emerging Biotech Companies
Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…
Jim Gallagher2021 年 1 月 21 日
Be Honest, Be Reliable, Be Human: Insights from a Global Drug Development Expert
One of the most exciting things about working in the pharmaceutical industry is the ability…
Suzanne Minton2020 年 12 月 16 日
Certara Opens New China Office in Shanghai
Office will support rapid growth and collaboration with customers in China to accelerate biopharmaceutical R&D …
Certara2020 年 11 月 9 日
Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development
Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic…
Leticia Arrington2019 年 12 月 19 日
